文献速递肝病

胆管上皮细胞调控肝脏CD100表达并促进致病性辅助性T细胞17分化

Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation.
PubMed 文献 · Gastroenterology · 2023-11-22

本研究围绕原发性硬化性胆管炎(PSC)的因果突变CD100 K849T,利用肝活检标本的空间转录组学、免疫成像和高维流式细胞术,以及突变小鼠脾细胞与胆管上皮细胞共培养模型,发现CD100主要由肝脏免疫细胞表达,在PSC胆管周围呈RNA水平共定位而蛋白水平检测不佳,与可溶性CD100增加有关;胆管浸润T细胞是可溶性CD100的主要来源,粘附于胆管上皮细胞的致病性T细胞上调辅助性T细胞17分化通路基因,CD100突变增强该过程,患者胆管驻留CD4 T细胞以辅助性T细胞17为主。

要点

  • PSC胆管周围CD100呈RNA水平共定位而蛋白水平检测不佳,可溶性CD100增加。
  • 胆管浸润T细胞是可溶性CD100的主要来源。
  • 粘附于胆管上皮细胞的致病性T细胞上调辅助性T细胞17分化通路基因,CD100突变增强该过程。

核心结论

  • CD100通过胆管上皮细胞与免疫细胞之间的交叉对话发挥功能影响,凸显胆管上皮细胞主动的促炎作用,可能与新的治疗途径相关。

研究设计与样本

  • 使用移植肝活检标本和内镜引导采样,通过空间转录组学、免疫成像和高维流式细胞术评估CD100表达。
  • 将突变特异性小鼠的脾细胞与胆管上皮细胞共培养以模拟致病性胆管上皮细胞-免疫细胞相互作用。
  • 通过对共培养细胞进行RNA测序分析确定致病通路,并在患者材料中交叉验证。

主要发现

  • CD100主要由肝脏免疫细胞表达,在PSC胆管周围呈独特模式:RNA水平共定位但蛋白水平检测不佳,可能与CD100裂解导致可溶性CD100增加有关。
  • 免疫表型分析提示胆管浸润T细胞是可溶性CD100的主要来源,共培养后T细胞表面CD100减少、胆管上皮细胞金属蛋白酶增加进一步支持此点。
  • 粘附于胆管上皮细胞的致病性T细胞上调辅助性T细胞17分化通路基因,CD100突变增强该过程;患者胆管驻留CD4 T细胞以辅助性T细胞17为主。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chronic inflammation surrounding bile ducts contributes to the disease pathogenesis of most cholangiopathies. Poor efficacy of immunosuppression in these conditions suggests biliary-specific pathologic principles. Here we performed biliary niche specific functional interpretation of a causal mutation (CD100 K849T) of primary sclerosing cholangitis (PSC) to understand related pathogenic mechanisms. METHODS: Biopsy specimens of explanted livers and endoscopy-guided sampling were used to assess the CD100 expression by spatial transcriptomics, immune imaging, and high-dimensional flow cytometry. To model pathogenic cholangiocyte-immune cell interaction, splenocytes from mutation-specific mice were cocultured with cholangiocytes. Pathogenic pathways were pinpointed by RNA sequencing analysis of cocultured cells and cross-validated in patient materials. RESULTS: CD100 is mainly expressed by immune cells in the liver and shows a unique pattern around PSC bile ducts with RNA-level colocalization but poor detection at the protein level. This appears to be due to CD100 cleavage as soluble CD100 is increased. Immunophenotyping suggests biliary-infiltrating T cells as the major source of soluble CD100, which is further supported by reduced surface CD100 on T cells and increased metalloproteinases in cholangiocytes after coculturing. Pathogenic T cells that adhered to cholangiocytes up-regulated genes in the T-helper 17 cell differentiation pathway, and the CD100 mutation boosted this process. Consistently, T-helper 17 cells dominate biliary-resident CD4 T cells in patients. CONCLUSIONS: CD100 exerts its functional impact through cholangiocyte-immune cell cross talk and underscores an active, proinflammatory role of cholangiocytes that can be relevant to novel treatment approaches.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Jiang X, Otterdal K, Chung BK, et al. Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation. Gastroenterology. 2023. PMID: 37995866. doi:10.1053/j.gastro.2023.11.283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。